fingolimod hydrochloride has been researched along with Anterior Cerebral Circulation Infarction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haghani, M; Keshavarz, S; Namavar, MR; Nazari, M; Rafati, A | 1 |
| Fluri, F; Kleinschnitz, C; Krstic, M; Schuhmann, MK | 1 |
| Friedlander, RM; Lin, N | 1 |
3 other study(ies) available for fingolimod hydrochloride and Anterior Cerebral Circulation Infarction
| Article | Year |
|---|---|
Fingolimod (FTY720) improves hippocampal synaptic plasticity and memory deficit in rats following focal cerebral ischemia.
Topics: Animals; Avoidance Learning; Brain Infarction; Disease Models, Animal; Fingolimod Hydrochloride; Hippocalcin; Immunosuppressive Agents; Infarction, Middle Cerebral Artery; Long-Term Potentiation; Lymphocytes; Male; Memory Disorders; Neurologic Examination; Neuronal Plasticity; Neutrophils; Rats; Rats, Sprague-Dawley; Reperfusion; Time Factors | 2016 |
Fingolimod (FTY720) Reduces Cortical Infarction and Neurological Deficits During Ischemic Stroke Through Potential Maintenance of Microvascular Patency.
Topics: Animals; Brain; Brain Infarction; Brain Ischemia; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Fingolimod Hydrochloride; Infarction, Middle Cerebral Artery; Male; Mice, Inbred C57BL; Microvessels; Stroke | 2016 |
T-cell activation in ischemic stroke: a new therapeutic target for delayed infarct expansion?
Topics: Animals; Brain Infarction; Cytokines; Disease Models, Animal; Fingolimod Hydrochloride; Immunosuppressive Agents; Infarction, Middle Cerebral Artery; Interleukin-17; Interleukin-23; Mice; Mice, Knockout; Propylene Glycols; Sphingosine; T-Lymphocytes | 2009 |